Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma

摘要

Background: The number of people who inject performance and image enhancing drugs (PIEDs) attending Australian needle syringe programs (NSPs) has increased recently with cost and capacity implications for this already stretched public health program. The need to prioritise populations' NSP access poses dilemmas for a program that has always sought to minimise entry barriers.